Abstract: A method of treating an aneurysm with an occlusion device having an inner embolic device with a proximal section and a distal section. The distal section has a first stiffness and the proximal section has a second stiffness. Further, the device has an expandable mesh capable of a collapsed position and an expanded position. The mesh can be disposed over, and attached to, a portion of the proximal section of the inner embolic device. The first stiffness is greater than the second stiffness and the inner embolic device comprises a preselected shape which assists in transforming the expandable mesh from the collapsed position to the expanded position.

Abstract: An occlusion device for treating an aneurysm can have an inner embolic device with a proximal section and a distal section. The distal section has a first stiffness and the proximal section has a second stiffness. Further, the device has an expandable mesh capable of a collapsed position and an expanded position. The mesh can be disposed over, and attached to, a portion of the proximal section of the inner embolic device. The first stiffness is greater than the second stiffness and the inner embolic device has a preselected shape which assists in transforming the expandable mesh from the collapsed position to the expanded position.

Abstract: The present disclosure relates to a self-expanding braided tubular member for treating an aneurysm. The braid can include a distal implant end opposite a proximal implant end. Translating the braid distally from within a tubular delivery member can cause the distal implant end to invert and fold into itself thereby forming an occlusive sack for occluding an aneurysm.

Abstract: A vascular flow diverter includes a tubular mesh framework which includes a mesh cover and an opening. The tubular mesh framework is collapsible and configured to expand from a collapsed shape to a tubular shape when the vascular flow diverter is deployed. The mesh cover conforms to the shape of the tubular mesh, is surrounded by the tubular mesh framework, and is less porous than the tubular mesh framework. The opening is located within the mesh cover. A delivery wire passes through the opening in order to guide the flow diverter into place over an aneurysm.

Abstract: Systems and methods for delivering a catheter to a location of interest in the vasculature, the method including selectively positioning a guidewire at the location, positioning a self-expanding sheath within a lumen of the catheter, advancing the catheter and the self-expanding sheath in tandem over the guidewire, and distally moving a distal end of the self-expanding sheath out from an inner lumen of the catheter thereby causing the self-expanding sheath to move from a collapsed state within the catheter to an expanded state outside the catheter.

Abstract: An embolic device deployment system having a lumen with proximal and distal ends. An embolic device having a proximal retaining ring and an expandable member having a contracted and expanded state, with two apertures. The expandable member is disposed in the lumen in the expanded state. An engagement member has a distal loop extending through the retaining ring and a proximal loop extending into the lumen. The detachment member slides within the lumen and another of the apertures and is disposed through the loops. It comprises a bump on the detachment member between the loops. When the detachment member is in the distal loop and the distal loop is disposed within the retaining ring, the embolic device is in an engaged position. Pulling the detachment member withdraws it from the distal loop. The bump contacts the proximal loop to assist in the disengagement of the distal loop from the retaining ring to release the embolic device.

Abstract: A mechanism can include a step feature guidewire having a guidewire with a proximal end, a distal end, and a diameter. A self-expanding element can be disposed approximate to the distal end of the guidewire and can have at least two states which include a contracted diameter and an expanded diameter. The self-expanding element can be expandable under its inherent properties, based at least on its original shape and the nature of the materials that make up the element. Further, the expanded diameter can be approximately 70% to 280% of the guidewire diameter. While the guidewire is designed for passing through a body lumen while treating a patient, the expanded diameter is less than any body lumen diameter the guidewire is determined to pass through.

Abstract: A braided stent system includes a stent body having a lumen formed by a plurality of braided members with interstices formed therebetween and a first expansion ring connected to the lumen of the stent body. The first expansion ring may include a frame defined by a plurality of interconnected support assemblies that are selectively positioned to impart an outwardly expanding radial force to the stent body, each support assembly can include a plurality of legs joined at a first intersection and connected to one of the other interconnected support assemblies at a second intersection opposite the first intersection. Each support assembly can include a claw portion mechanically connected to one or more of the interstices of the stent body so that the frame imparts an outward radial expansion force of the stent to facilitate use and delivery of the stent.

Abstract: An embolic device deployment system includes a catheter having a first lumen and proximal and distal ends. A notch is disposed in the first lumen, forming a second lumen. An embolic device has a retaining ring at the proximal end. An engagement member includes a distal loop extending through the retaining ring, and a proximal loop extending into the first lumen. An elongated detachment member can be disposed through the loops and have a detachment member bump disposed between the loops. When the detachment member is disposed within the distal loop and the distal loop is disposed within the retaining ring, the embolic device is engaged. When the detachment member is pulled proximally, the detachment member is withdrawn from the distal loop, and the detachment member bump contacts the proximal loop. These acts assist in the disengagement of the distal loop from the retaining ring to release the embolic device.

Abstract: An endovascular surgical tool includes a flexible, electrically-conductive corewire, a return conductor, a resistive heating element attached to the distal end of the corewire, and a therapeutic payload attached to the loop of the resistive heating element by a coil connecting member. The corewire includes at least one segment at its distal end which transitions from the substantially uniform cross-section of its proximal end to a smaller distal cross-section. The return conductor is electrically insulated from and bonded to the corewire. The resistive heating element includes a first terminal electrically connected to the corewire, a second terminal electrically connected to the return conductor, a helical coil, and a loop. The helical coil and the loop are electrically in series between the first terminal and the second terminal. The coil connecting member has a release temperature lower than a loop melting temperature of the loop of the resistive heating element.

Abstract: An occlusion device for treating an aneurysm can have an inner embolic device with a proximal section and a distal section. The distal section has a first stiffness and the proximal section has a second stiffness. Further, the device has an expandable mesh capable of a collapsed position and an expanded position. The mesh can be disposed over, and attached to, a portion of the proximal section of the inner embolic device. The first stiffness is greater than the second stiffness and the inner embolic device comprises a preselected shape which assists in transforming the expandable mesh from the collapsed position to the expanded position.

Abstract: A mechanism can include a step feature guidewire having a guidewire with a proximal end, a distal end, and a diameter. A self-expanding element can be disposed approximate to the distal end of the guidewire and can have at least two states which include a contracted diameter and an expanded diameter. The self-expanding element can be expandable under its inherent proprieties, based at least on its original shape and the nature of the materials that make up the element. Further, the expanded diameter can be approximately 70% to 280% of the guidewire diameter. While the guidewire is designed for passing through a body lumen while treating a patient, the expanded diameter is less than any body lumen diameter the guidewire is determined to pass through.

Abstract: An embolic device deployment system includes a catheter having a first lumen and proximal and distal ends. A notch is disposed in the first lumen, forming a second lumen. An embolic device has a retaining ring at the proximal end. An engagement member includes a distal loop extending through the retaining ring, and a proximal loop extending into the first lumen. An elongated detachment member can be disposed through the loops and have a detachment member bump disposed between the loops. When the detachment member is disposed within the distal loop and the distal loop is disposed within the retaining ring, the embolic device is engaged. When the detachment member is pulled proximally, the detachment member is withdrawn from the distal loop, and the detachment member bump contacts the proximal loop. These acts assist in the disengagement of the distal loop from the retaining ring to release the embolic device.

Abstract: Provided herein are a system, method, and apparatus for delivering a therapeutic device, e.g. an embolic coil, from a delivery tube at a target site in a patient's body. A heating element is disposed in the delivery tube that can be actuated remotely, and a layer of low temperature adhesive is applied at the heating element to retain the therapeutic device. The kicker in the form of, for example, a compressed spring is mounted within the delivery tube so as to be in contact with the therapeutic device for applying a constant ejector force that is countered by the adhesive force of the low temperature adhesive. When the heating element is actuated, the spring's ejector force overcomes the softened adhesive's adhesive force to force the therapeutic device out of the delivery tube.

Abstract: A stretch-resistant occlusive device, and method of manufacturing such a device, having a helically wound coil defining a coil lumen extending along the entire axial length of the coil from a proximal end portion to a distal end portion. The device further includes a headpiece having a proximal end, a distal end attached to the proximal end portion of the coil, and a headpiece lumen extending between the proximal and distal ends of the headpiece. An anchor filament extends through the headpiece lumen, has at least one proximal end secured to the proximal end of the headpiece, and has a distal portion defining an eye positioned distal to the distal end of the headpiece. A stretch resistant member is positioned within the coil lumen, has a proximal portion extending through the eye, and has at least one distal end secured to the distal end of the coil.

Abstract: An occlusion device suitable for endovascular treatment of an aneurysm in a blood vessel in a patient, including a substantially tubular structure having a proximal end region and a distal end region, having a first, expanded condition and a second, collapsed condition. The device has dimensions in the second, collapsed condition suitable for insertion through vasculature of the patient and through a neck of the aneurysm. The device further includes a control ring having a substantially annular body disposed on the proximal end region of the structure and at least substantially circumscribing the proximal end region to prevent radial expansion of the proximal end region and to provide an engagement feature during manipulation of the occlusion device.

Abstract: The present invention refers to a stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo[2.2.2]oct-3-yl ester and its use as medicament, in particular for the treatment of urinary incontinence or other diseases involving genitourinary disorders.

Abstract: The compounds of formula (I) are derived from perhydroquinoline and perhydroisoquinoline and are useful as active pharmaceutical ingredients for the prophylaxis or treatment of diseases caused by 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD1) enzyme-associated disorders, such as glaucoma, elevated ocular pressure, metabolic disorders, obesity, metabolic syndrome, dyslipidemia, hypertension, diabetes, atherosclerosis, Cushing's syndrome, psoriasis, rheumatoid arthritis, cognitive disorders, Alzheimer's disease or neurodegeneration.